New Analyzer System from Thermo Achieves Non-Destructive Protein Analysis
October 31, 2005
MADISON, Wisconsin - Thermo Electron Corporation (NYSE: TMO) announces the launch of its new complete instrumentation package for the analysis of proteins, the Proteus protein analyzer system. The system is based on Fourier transform infrared (FT-IR) technology and uses a Nicolet series FT-IR spectrometer to non-destructively scan protein samples for structural defect and impurity analysis [...]
Applied Biosystems to Invest in VisiGen Biotechnologies
October 26, 2005
Next Generation Sequencing Technology May Hold Promise of the $1,000 Genome FOSTER CITY, Calif. & HOUSTON--Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and VisiGen Biotechnologies, Inc., announced today that Applied Biosystems has signed a definitive agreement to make an equity investment in privately held VisiGen, a next-generation sequencing technology company, and to enter into [...]
October 26, 2005
ROCKY HILL, N.J.--Bruker AXS Inc.today announced an agreement to acquire the PGT X-ray microanalysis business with annual revenues of $5-6 million from Princeton Gamma-Tech Instruments, Inc. The terms of the transaction were not disclosed, and the acquisition is expected to close in the fourth quarter of 2005. On October 14, 2005, Bruker AXS had announced [...]
Bio-Rad Signs Second Collaboration Agreement with Caliper
October 25, 2005
-Companies to Investigate Development of Another Novel Microfluidic System- HERCULES, Calif. and HOPKINTON, Mass.-- Bio-Rad Laboratories, Inc. (Amex: BIO and BIOb) and Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced a new collaboration, under which the companies will study the feasibility of developing a new microfluidics system platform. Details of the new product concept are [...]
FEI Company Reports Results for Third Quarter of 2005
October 25, 2005
HILLSBORO, Ore. -- FEI Company (Nasdaq: FEIC) reported results for the third quarter of 2005. While revenue declined from the level of the second quarter, the company also reduced its operating expenses. The company expects higher revenue in the fourth quarter of 2005 and improved financial results for 2006. Net sales for the quarter ended [...]
October 24, 2005
Oxford Instruments introduces the X-Strata960+ for measuring coating thickness and composition by XRF. The X-Strata960+ is the latest evolution of the industry leading X-Strata series. This new, high precision instrument, is specifically designed for gold analysis in the electronics industry. A number of significant new features have been incorporated into X-Strata960+ and the key elements [...]
October 24, 2005
Fullerton, California, - Beckman Coulter, Inc. introduces Cell Lab Quanta SC - the second offering in its new family of affordable flow cytometers for drug discovery and basic clinical research. The Quanta SC combines side light scatter detection and a third fluorescent channel with Coulter volume measurement to deliver accurate, multiparameter cell counting and sizing. [...]
October 24, 2005
SANTA CLARA, Calif..--Affymetrix Inc. (Nasdaq:AFFX) today announced the completion of its acquisition of privately held ParAllele BioScience, Inc., a provider of highly-scalable technology for comprehensive genetic studies. In connection with the completion of the acquisition, ParAllele stockholders will receive approximately $120.8 million in the form of approximately 2.29 million shares of Affymetrix common stock and [...]
Sartorius presents nine-month figures
October 20, 2005
Goettingen, October 20, 2005 – The Sartorius Group, a leading laboratory and process equipment provider worldwide, closed the first nine months of the year 2005 with increases in sales revenue and earnings. The Biotechnology Division in particular grew profitably because of the excellent development of its filter business for biopharmaceutical applications. The Mechatronics Division with [...]
Dharmacon and Alcon to Collaborate on Discovery of New Therapies for Eye Diseases Using RNAi
October 19, 2005
LAFAYETTE, Colo. -- Dharmacon, Inc., a business unit of the Fisher Biosciences group, and the world's leading supplier of innovative RNA and RNA interference (RNAi) research products, today announced a collaboration to develop a new class of therapeutic agents based on RNA interference with Alcon Research, Ltd. and Alcon Manufacturing, Ltd., affiliates of Alcon, Inc. [...]
